• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of Intraocular Bleeding and the New Anticoagulants: Not Such a Big Effect-Reply.

作者信息

Sun Michelle T, Wong Christopher X

机构信息

South Australian Institute of Ophthalmology, The University of Adelaide and Royal Adelaide Hospital, Adelaide, South Australia.

Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia.

出版信息

JAMA Ophthalmol. 2017 Nov 1;135(11):1281-1282. doi: 10.1001/jamaophthalmol.2017.4024.

DOI:10.1001/jamaophthalmol.2017.4024
PMID:28983572
Abstract
摘要

相似文献

1
Risk of Intraocular Bleeding and the New Anticoagulants: Not Such a Big Effect-Reply.
JAMA Ophthalmol. 2017 Nov 1;135(11):1281-1282. doi: 10.1001/jamaophthalmol.2017.4024.
2
Risk of Intraocular Bleeding and the New Anticoagulants: Not Such a Big Effect.眼内出血风险与新型抗凝剂：影响并非如此巨大。
JAMA Ophthalmol. 2017 Nov 1;135(11):1281. doi: 10.1001/jamaophthalmol.2017.4021.
3
Risk of intraocular hemorrhage with new oral anticoagulants.新型口服抗凝剂导致眼内出血的风险。
Eye (Lond). 2017 Apr;31(4):628-631. doi: 10.1038/eye.2016.265. Epub 2016 Dec 23.
4
Risk of Substantial Intraocular Bleeding With Novel Oral Anticoagulants: Systematic Review and Meta-analysis.新型口服抗凝剂致严重眼内出血的风险：系统评价和荟萃分析。
JAMA Ophthalmol. 2015 Jul;133(7):834-9. doi: 10.1001/jamaophthalmol.2015.0985.
5
A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants.一项全国性注册研究，旨在比较服用口服抗凝剂的心房颤动患者的出血率。
Eur Heart J Cardiovasc Pharmacother. 2017 Jan;3(1):28-36. doi: 10.1093/ehjcvp/pvw031. Epub 2016 Sep 27.
6
Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study.达比加群、利伐沙班和华法林导致胃肠道出血的比较风险：基于人群的队列研究。
BMJ. 2015 Apr 24;350:h1857. doi: 10.1136/bmj.h1857.
7
Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.达比加群或利伐沙班与维生素K拮抗剂新治疗的非瓣膜性心房颤动患者出血和动脉血栓栓塞事件短期风险的比较：一项法国全国性倾向匹配队列研究。
Circulation. 2015 Sep 29;132(13):1252-60. doi: 10.1161/CIRCULATIONAHA.115.015710. Epub 2015 Jul 21.
8
Risk of intraocular hemorrhage with oral anticoagulants in ocular surgery.眼科手术中口服抗凝剂导致眼内出血的风险。
Eye (Lond). 2018 Feb;32(2):471-472. doi: 10.1038/eye.2017.185. Epub 2017 Sep 1.
9
Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection.直接口服抗凝剂对胃内镜黏膜下剥离术后延迟出血风险的影响。
Dig Endosc. 2017 Sep;29(6):686-694. doi: 10.1111/den.12859. Epub 2017 Apr 24.
10
Novel Antithrombotic Drugs and Intraocular Bleeding: The Importance of Observational Data and Future Perspectives.
JAMA Ophthalmol. 2018 Feb 1;136(2):130-131. doi: 10.1001/jamaophthalmol.2017.4179.